Anemia after kidney transplantation: Does its basis differ from anemia in chronic kidney disease?

Background Although similar factors play a role in both PTA and anemia in patients with CKD, additional risk factors exist in the pathogenesis of PTA. The present study aimed at comparing anemia and inflammation‐related parameters between RTx recipients and CKD patients and elucidating the risk fact...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric transplantation 2020-12, Vol.24 (8), p.e13818-n/a
Hauptverfasser: Oruç, Çiğdem, Canpolat, Nur, Pehlivan, Esra, Balcı Ekmekçi, Özlem, Ağbaş, Ayşe, Çalışkan, Salim, Sever, Fatma Lale
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 8
container_start_page e13818
container_title Pediatric transplantation
container_volume 24
creator Oruç, Çiğdem
Canpolat, Nur
Pehlivan, Esra
Balcı Ekmekçi, Özlem
Ağbaş, Ayşe
Çalışkan, Salim
Sever, Fatma Lale
description Background Although similar factors play a role in both PTA and anemia in patients with CKD, additional risk factors exist in the pathogenesis of PTA. The present study aimed at comparing anemia and inflammation‐related parameters between RTx recipients and CKD patients and elucidating the risk factors of PTA. Methods This single‐centered, cross‐sectional study consisted of 68 participants: 48 were in the RTx group and 20 were in the CKD group. The CKD patients were comparable to the RTx recipients in terms of age, gender, and eGFR. Serum levels of EPO, hepcidin, and IL‐6 were measured by enzyme‐linked immunosorbent assays. The ratio of EPO/Hb was calculated to estimate endogenous EPO resistance. Results The prevalence of anemia was 46% in the RTx group and 30% in the CKD group (P = .23). RTx recipients had significantly lower Hb (P = .04), higher EPO (P 
doi_str_mv 10.1111/petr.13818
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2434482303</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2462458255</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3578-2317753fc5f1ee7c7a83dbea297f043dade07ac0ccc163b48df8f76ad2ee946d3</originalsourceid><addsrcrecordid>eNp90MtKAzEUBuAgiq3VjQ8gATciTM1tJhk3It5BUKSuhzQ5wdTOTE2mSN_e2LEuXJjNyeLLz8mP0CElY5rO2QK6MKZcUbWFhpSXZcaJKLbXd5lxKtgA7cU4I4QWQoldNOBMlrKQfIj0ZQO111i7DgJ-97aBFe6CbuJirptOd75tzvF1CxH7LuKpjj5i651L2oW2xrp_7xts3kLbeLMJsT6CjnCxj3acnkc4-Jkj9Hp7M7m6zx6f7h6uLh8zw3OpMsaplDl3JncUQBqpFbdT0KyUjghutQUitSHGGFrwqVDWKScLbRlAKQrLR-ikz12E9mMJsatqHw3M0zegXcaKCS6EYpzwRI__0Fm7DE3aLqmCiVyxPE_qtFcmtDEGcNUi-FqHVUVJ9V189V18tS4-4aOfyOW0BvtLN00nQHvw6eew-ieqer6ZvPShX7jPjrc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2462458255</pqid></control><display><type>article</type><title>Anemia after kidney transplantation: Does its basis differ from anemia in chronic kidney disease?</title><source>Wiley Online Library All Journals</source><creator>Oruç, Çiğdem ; Canpolat, Nur ; Pehlivan, Esra ; Balcı Ekmekçi, Özlem ; Ağbaş, Ayşe ; Çalışkan, Salim ; Sever, Fatma Lale</creator><creatorcontrib>Oruç, Çiğdem ; Canpolat, Nur ; Pehlivan, Esra ; Balcı Ekmekçi, Özlem ; Ağbaş, Ayşe ; Çalışkan, Salim ; Sever, Fatma Lale</creatorcontrib><description>Background Although similar factors play a role in both PTA and anemia in patients with CKD, additional risk factors exist in the pathogenesis of PTA. The present study aimed at comparing anemia and inflammation‐related parameters between RTx recipients and CKD patients and elucidating the risk factors of PTA. Methods This single‐centered, cross‐sectional study consisted of 68 participants: 48 were in the RTx group and 20 were in the CKD group. The CKD patients were comparable to the RTx recipients in terms of age, gender, and eGFR. Serum levels of EPO, hepcidin, and IL‐6 were measured by enzyme‐linked immunosorbent assays. The ratio of EPO/Hb was calculated to estimate endogenous EPO resistance. Results The prevalence of anemia was 46% in the RTx group and 30% in the CKD group (P = .23). RTx recipients had significantly lower Hb (P = .04), higher EPO (P &lt; .001), and ferritin levels (P = .001), and higher EPO/Hb ratios (P &lt; .001); however, CKD patients showed a higher frequency of absolute iron deficiency (P = .008). Neither hepcidin nor IL‐6 levels differed between the two groups. Hb level of RTx recipients was correlated with only eGFR (r = .437, P = .002) but not with any of the transplantation‐related factors, while Fe level was the only parameter to be correlated with Hb level of CKD patients (r = .622, P = .01). Conclusion In the present study comparing GFR‐matched RTx and CKD patients, lower GFR level appears to be the factor most strongly associated with anemia, and endogenous EPO resistance is among the contributing factors to PTA.</description><identifier>ISSN: 1397-3142</identifier><identifier>EISSN: 1399-3046</identifier><identifier>DOI: 10.1111/petr.13818</identifier><identifier>PMID: 32797673</identifier><language>eng</language><publisher>Denmark: Wiley Subscription Services, Inc</publisher><subject>Anemia ; Epidermal growth factor receptors ; erythropoietin resistance ; Ferritin ; Hepcidin ; Iron deficiency ; Kidney diseases ; Kidney transplantation ; Kidney transplants ; Nutrient deficiency ; post‐transplant anemia ; Risk factors ; Serum levels</subject><ispartof>Pediatric transplantation, 2020-12, Vol.24 (8), p.e13818-n/a</ispartof><rights>2020 Wiley Periodicals LLC</rights><rights>2020 Wiley Periodicals LLC.</rights><rights>2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3578-2317753fc5f1ee7c7a83dbea297f043dade07ac0ccc163b48df8f76ad2ee946d3</citedby><cites>FETCH-LOGICAL-c3578-2317753fc5f1ee7c7a83dbea297f043dade07ac0ccc163b48df8f76ad2ee946d3</cites><orcidid>0000-0002-6315-2138 ; 0000-0002-3316-8032 ; 0000-0002-3420-9756 ; 0000-0002-3658-8622 ; 0000-0002-5918-6204 ; 0000-0001-7432-9915 ; 0000-0002-9659-0601</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpetr.13818$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpetr.13818$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32797673$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oruç, Çiğdem</creatorcontrib><creatorcontrib>Canpolat, Nur</creatorcontrib><creatorcontrib>Pehlivan, Esra</creatorcontrib><creatorcontrib>Balcı Ekmekçi, Özlem</creatorcontrib><creatorcontrib>Ağbaş, Ayşe</creatorcontrib><creatorcontrib>Çalışkan, Salim</creatorcontrib><creatorcontrib>Sever, Fatma Lale</creatorcontrib><title>Anemia after kidney transplantation: Does its basis differ from anemia in chronic kidney disease?</title><title>Pediatric transplantation</title><addtitle>Pediatr Transplant</addtitle><description>Background Although similar factors play a role in both PTA and anemia in patients with CKD, additional risk factors exist in the pathogenesis of PTA. The present study aimed at comparing anemia and inflammation‐related parameters between RTx recipients and CKD patients and elucidating the risk factors of PTA. Methods This single‐centered, cross‐sectional study consisted of 68 participants: 48 were in the RTx group and 20 were in the CKD group. The CKD patients were comparable to the RTx recipients in terms of age, gender, and eGFR. Serum levels of EPO, hepcidin, and IL‐6 were measured by enzyme‐linked immunosorbent assays. The ratio of EPO/Hb was calculated to estimate endogenous EPO resistance. Results The prevalence of anemia was 46% in the RTx group and 30% in the CKD group (P = .23). RTx recipients had significantly lower Hb (P = .04), higher EPO (P &lt; .001), and ferritin levels (P = .001), and higher EPO/Hb ratios (P &lt; .001); however, CKD patients showed a higher frequency of absolute iron deficiency (P = .008). Neither hepcidin nor IL‐6 levels differed between the two groups. Hb level of RTx recipients was correlated with only eGFR (r = .437, P = .002) but not with any of the transplantation‐related factors, while Fe level was the only parameter to be correlated with Hb level of CKD patients (r = .622, P = .01). Conclusion In the present study comparing GFR‐matched RTx and CKD patients, lower GFR level appears to be the factor most strongly associated with anemia, and endogenous EPO resistance is among the contributing factors to PTA.</description><subject>Anemia</subject><subject>Epidermal growth factor receptors</subject><subject>erythropoietin resistance</subject><subject>Ferritin</subject><subject>Hepcidin</subject><subject>Iron deficiency</subject><subject>Kidney diseases</subject><subject>Kidney transplantation</subject><subject>Kidney transplants</subject><subject>Nutrient deficiency</subject><subject>post‐transplant anemia</subject><subject>Risk factors</subject><subject>Serum levels</subject><issn>1397-3142</issn><issn>1399-3046</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp90MtKAzEUBuAgiq3VjQ8gATciTM1tJhk3It5BUKSuhzQ5wdTOTE2mSN_e2LEuXJjNyeLLz8mP0CElY5rO2QK6MKZcUbWFhpSXZcaJKLbXd5lxKtgA7cU4I4QWQoldNOBMlrKQfIj0ZQO111i7DgJ-97aBFe6CbuJirptOd75tzvF1CxH7LuKpjj5i651L2oW2xrp_7xts3kLbeLMJsT6CjnCxj3acnkc4-Jkj9Hp7M7m6zx6f7h6uLh8zw3OpMsaplDl3JncUQBqpFbdT0KyUjghutQUitSHGGFrwqVDWKScLbRlAKQrLR-ikz12E9mMJsatqHw3M0zegXcaKCS6EYpzwRI__0Fm7DE3aLqmCiVyxPE_qtFcmtDEGcNUi-FqHVUVJ9V189V18tS4-4aOfyOW0BvtLN00nQHvw6eew-ieqer6ZvPShX7jPjrc</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Oruç, Çiğdem</creator><creator>Canpolat, Nur</creator><creator>Pehlivan, Esra</creator><creator>Balcı Ekmekçi, Özlem</creator><creator>Ağbaş, Ayşe</creator><creator>Çalışkan, Salim</creator><creator>Sever, Fatma Lale</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6315-2138</orcidid><orcidid>https://orcid.org/0000-0002-3316-8032</orcidid><orcidid>https://orcid.org/0000-0002-3420-9756</orcidid><orcidid>https://orcid.org/0000-0002-3658-8622</orcidid><orcidid>https://orcid.org/0000-0002-5918-6204</orcidid><orcidid>https://orcid.org/0000-0001-7432-9915</orcidid><orcidid>https://orcid.org/0000-0002-9659-0601</orcidid></search><sort><creationdate>202012</creationdate><title>Anemia after kidney transplantation: Does its basis differ from anemia in chronic kidney disease?</title><author>Oruç, Çiğdem ; Canpolat, Nur ; Pehlivan, Esra ; Balcı Ekmekçi, Özlem ; Ağbaş, Ayşe ; Çalışkan, Salim ; Sever, Fatma Lale</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3578-2317753fc5f1ee7c7a83dbea297f043dade07ac0ccc163b48df8f76ad2ee946d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anemia</topic><topic>Epidermal growth factor receptors</topic><topic>erythropoietin resistance</topic><topic>Ferritin</topic><topic>Hepcidin</topic><topic>Iron deficiency</topic><topic>Kidney diseases</topic><topic>Kidney transplantation</topic><topic>Kidney transplants</topic><topic>Nutrient deficiency</topic><topic>post‐transplant anemia</topic><topic>Risk factors</topic><topic>Serum levels</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oruç, Çiğdem</creatorcontrib><creatorcontrib>Canpolat, Nur</creatorcontrib><creatorcontrib>Pehlivan, Esra</creatorcontrib><creatorcontrib>Balcı Ekmekçi, Özlem</creatorcontrib><creatorcontrib>Ağbaş, Ayşe</creatorcontrib><creatorcontrib>Çalışkan, Salim</creatorcontrib><creatorcontrib>Sever, Fatma Lale</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oruç, Çiğdem</au><au>Canpolat, Nur</au><au>Pehlivan, Esra</au><au>Balcı Ekmekçi, Özlem</au><au>Ağbaş, Ayşe</au><au>Çalışkan, Salim</au><au>Sever, Fatma Lale</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anemia after kidney transplantation: Does its basis differ from anemia in chronic kidney disease?</atitle><jtitle>Pediatric transplantation</jtitle><addtitle>Pediatr Transplant</addtitle><date>2020-12</date><risdate>2020</risdate><volume>24</volume><issue>8</issue><spage>e13818</spage><epage>n/a</epage><pages>e13818-n/a</pages><issn>1397-3142</issn><eissn>1399-3046</eissn><abstract>Background Although similar factors play a role in both PTA and anemia in patients with CKD, additional risk factors exist in the pathogenesis of PTA. The present study aimed at comparing anemia and inflammation‐related parameters between RTx recipients and CKD patients and elucidating the risk factors of PTA. Methods This single‐centered, cross‐sectional study consisted of 68 participants: 48 were in the RTx group and 20 were in the CKD group. The CKD patients were comparable to the RTx recipients in terms of age, gender, and eGFR. Serum levels of EPO, hepcidin, and IL‐6 were measured by enzyme‐linked immunosorbent assays. The ratio of EPO/Hb was calculated to estimate endogenous EPO resistance. Results The prevalence of anemia was 46% in the RTx group and 30% in the CKD group (P = .23). RTx recipients had significantly lower Hb (P = .04), higher EPO (P &lt; .001), and ferritin levels (P = .001), and higher EPO/Hb ratios (P &lt; .001); however, CKD patients showed a higher frequency of absolute iron deficiency (P = .008). Neither hepcidin nor IL‐6 levels differed between the two groups. Hb level of RTx recipients was correlated with only eGFR (r = .437, P = .002) but not with any of the transplantation‐related factors, while Fe level was the only parameter to be correlated with Hb level of CKD patients (r = .622, P = .01). Conclusion In the present study comparing GFR‐matched RTx and CKD patients, lower GFR level appears to be the factor most strongly associated with anemia, and endogenous EPO resistance is among the contributing factors to PTA.</abstract><cop>Denmark</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32797673</pmid><doi>10.1111/petr.13818</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-6315-2138</orcidid><orcidid>https://orcid.org/0000-0002-3316-8032</orcidid><orcidid>https://orcid.org/0000-0002-3420-9756</orcidid><orcidid>https://orcid.org/0000-0002-3658-8622</orcidid><orcidid>https://orcid.org/0000-0002-5918-6204</orcidid><orcidid>https://orcid.org/0000-0001-7432-9915</orcidid><orcidid>https://orcid.org/0000-0002-9659-0601</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1397-3142
ispartof Pediatric transplantation, 2020-12, Vol.24 (8), p.e13818-n/a
issn 1397-3142
1399-3046
language eng
recordid cdi_proquest_miscellaneous_2434482303
source Wiley Online Library All Journals
subjects Anemia
Epidermal growth factor receptors
erythropoietin resistance
Ferritin
Hepcidin
Iron deficiency
Kidney diseases
Kidney transplantation
Kidney transplants
Nutrient deficiency
post‐transplant anemia
Risk factors
Serum levels
title Anemia after kidney transplantation: Does its basis differ from anemia in chronic kidney disease?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A31%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anemia%20after%20kidney%20transplantation:%20Does%20its%20basis%20differ%20from%20anemia%20in%20chronic%20kidney%20disease?&rft.jtitle=Pediatric%20transplantation&rft.au=Oru%C3%A7,%20%C3%87i%C4%9Fdem&rft.date=2020-12&rft.volume=24&rft.issue=8&rft.spage=e13818&rft.epage=n/a&rft.pages=e13818-n/a&rft.issn=1397-3142&rft.eissn=1399-3046&rft_id=info:doi/10.1111/petr.13818&rft_dat=%3Cproquest_cross%3E2462458255%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2462458255&rft_id=info:pmid/32797673&rfr_iscdi=true